ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679716 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679716; 2) Community: the network communities that were significantly associated with the response to NSC 679716; 3) Molecule: the relationships between components within communities and NSC 679716; 4) MDR: the compounds that were significantly associated with the NSC 679716.

NSC Compound Enrichment Correlation
NSC 763635 N-(benzo[d]thiazol-2-yl)-2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide 0.0244632509325736 0.18614207
NSC 105023 RUBIFLAVIN 0.0244718705444135 0.25937197
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0244718705444135 0.20107168
NSC 237538 2,4-Thiazolidinedione, 5-(3-phenyl-2-propenylidene)- 0.0244718705444135 0.22668648
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0244718705444135 0.35288847
NSC 281613 Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) 0.0244718705444135 0.11275481
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0244718705444135 0.11609959
NSC 373355 Saframycin R 0.0244718705444135 0.56322363
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0244718705444135 0.18582728
NSC 406666 Null 0.0244718705444135 0.16410976
Total:134  Current:86    [First] [Prev] [Next] [Last]